We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Medtronic

Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
09 Dec 2022 - 11 Dec 2022

Novel Endoscopic Hemostasis System Improves Visibility and Controls Upper GI Bleeding

By HospiMedica International staff writers
Posted on 03 Oct 2022
Print article
Image: The Nexpowder endoscopic hemostasis system has received U.S. FDA clearance (Photo courtesy of Medtronic)
Image: The Nexpowder endoscopic hemostasis system has received U.S. FDA clearance (Photo courtesy of Medtronic)

Gastrointestinal (GI) bleeding is a common condition worldwide accounting a significant proportion of hospital admissions and a major cause of morbidity and mortality. Annual bleeding incidence is approximately 80 to 150 per 100,000 population for upper GI bleeding and 20 to 30 per 100,000 for lower GI bleeding. In most cases, the standard of care for the diagnostic evaluation of suspected GI bleeding is urgent (within 24 hours) upper endoscopy or colonoscopy. Endoscopic hemostasis is frequently the first line treatment and are typically performed during upper or lower endoscopy using different devices available to the physician (clips, injection of agents, argon plasma coagulation, hemostasis graspers, sprays, bipolar probes, etc). Physicians frequently use more than one endoscopic device to achieve hemostasis. Now, a new endoscopic hemostasis system provides gastroenterologists improved visibility and controls upper GI bleeding effectively and with ease.

Developed independently by Next Biomedical Inc. (Korea) and distributed globally by Medtronic plc (Dublin, Ireland), the new Nexpowder endoscopic hemostasis system uses a noncontact, nonthermal and nontraumatic hemostatic powder sprayed through a catheter that has a propriety powder-coating technology for minimized clogging which provides improved visibility and control for treating upper GI nonvariceal bleeding.

Nexpowder is sprayed on to a target site endoscopically through a catheter that connects to a spray handle. Once sprayed, Nexpowder immediately forms a muco-adhesive and durable gel upon contact, with or without blood, which degrades in one-to-three days. The spray adheres to the tissue with double the adhesive force of other commercially available products, resulting in a durable hemostatic effect. Nexpowder delivers a precise solution for nonvariceal upper GI bleeding with minimal scattering or clogging, enabling direct endoscopic visibility without impairment.

Created with a unique delivery system that does not require CO2 or air compressors, the Nexpowder endoscopic hemostasis system combats the inefficiency of clogged catheters and cloudy fields of vision with a proprietary hydrophilic polymer to enable controlled delivery, minimize catheter clogging and maintain endoscopic visibility. The system responds to all types of moisture, not only blood.

“We are very excited to bring the innovative, Nexpowder system to gastroenterologists,” said Gio Di Napoli, president of the Gastrointestinal business, part of the Medical Surgical Portfolio at Medtronic. “We considered the potential impact on physicians and patients alike, by meeting a clear need to reduce mortality from upper GI bleeding, a condition that causes death for one out of every 1,000 people while also reducing rebleeding, which happens in 20% of all upper GI bleeding cases.”

“With a 94% immediate hemostasis rate and a 3.7% rebleeding rate, we’re thrilled to share this effective technology with gastroenterologists,” said Dr. Austin Chiang, M.D., M.P.H., chief medical officer of the Gastrointestinal business at Medtronic. “When we treat patients, we’re looking for immediate and lasting results when it matters most. The Nexpowder system is a powerful tool for GI professionals to add to their toolboxes.”

Related Links:
Next Biomedical Inc. 
Medtronic plc

BMP Whole Blood Analyzer: GEM Premier ChemSTAT
New
Gold Supplier
Blood Glucose Reference Analyzer
Nova Primary
New
Gold Supplier
Group A Streptococcus Antigen Test
OSOM Strep A Test
New
D-Dimer Test
Epithod 616 D-Dimer Kit

Print article
Radcal

Channels

AI

view channel
Image: AI transforms smartwatch ECG signals into a diagnostic tool for heart failure (Photo courtesy of Pexels)

AI-Based Smartwatch Accurately Detects Heart Failure Using ECG Signals

People with a weak heart pump might not have symptoms, but this common form of heart disease affects about 2% of the population and 9% of people over 60. When the heart cannot pump enough oxygen-rich blood,... Read more

Critical Care

view channel
Image: Quantra Hemostasis Analyzer (Photo courtesy of HemoSonics)

Next-Gen POC Whole Blood Hemostasis System Recognizes Specific Needs of EDs and ORs

Current hemostatic tests provide only a subset of needed information, or take too long to be useful in critical bleeding situations, forcing clinicians to use iterative transfusion protocols that do not... Read more

Patient Care

view channel
Image: Automated cleaning system allows endoscopes to be cleaned direct from clinic (Photo courtesy of Aston University)

World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance

Endoscopes are long, thin tubes with a light and camera at one end. Due to the sensitivity of the materials and electronics they cannot be sterilized in an autoclave (a machine that uses steam under pressure),... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Business

view channel
Image: The global multiparameter patient monitoring systems market is expected to surpass USD 15 billion by 2028 (Photo courtesy of Unsplash)

Global Multiparameter Patient Monitoring Systems Market Driven by Rising Chronic Illnesses

Multi-parameter patient monitoring equipment is used to assess the vital signs of patients who are suffering from a serious illness. These devices are meant to give the number of data sets on one screen... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.